Bio-Rad Laboratories Inc Class A (BIO)
Bio-Rad Laboratories Inc Class A is a common stock listing on the NYSE for Bio-Rad Laboratories, Inc., a healthcare company focused on life science research and clinical diagnostics. The company develops, manufactures, and distributes products used in research and biopharmaceutical laboratory settings, including tools for separating, purifying, characterizing, and quantifying biological materials such as cells, proteins, and nucleic acids. Its life science offerings also support biopharmaceutical manufacturing, quality control, food safety, and science education. In clinical diagnostics, Bio-Rad provides diagnostic test systems, informatics platforms, test kits, quality controls, and software for hospitals, reference laboratories, transfusion services, and physician office laboratories. The company sells through a direct commercial organization and through distributors, agents, brokers, and resellers. Founded in 1952 and headquartered in Hercules, California, Bio-Rad operates across the United States, Europe, Asia, Canada, Latin America, and other international markets.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-BIO
|
$410.22
|
12.0% Upside
|
Fair
|
$356.67
|
-2.6% Downside
|
Fair
|
Good
|
0.0%
|
February 18, 2027
|
9.8x
|
1.3x
|
3.9x
|
10.062 B
|
3.489 B
|
11.9%
|
80.0%
|
3.7
|
32.2%
|